Jack Henry & Associates
JKHY
$134.03
-5.23%
Jack Henry & Associates is a leading provider of core processing, electronic funds transfer, payment processing, and loan processing services for U.S. banks and credit unions, operating within the Information Technology Services industry. The company has established a distinct competitive identity as a trusted, long-term technology partner focused on the small and midsize financial institution segment, serving nearly 1,000 banks and over 700 credit unions. The current investor narrative centers on the company's resilience and growth trajectory amidst a challenging macro environment for financial technology, with recent attention likely focused on its ability to maintain steady revenue growth and profitability despite the stock's significant underperformance relative to the broader market over the past year.…
JKHY
Jack Henry & Associates
$134.03
Investment Opinion: Should I buy JKHY Today?
Rating & Thesis: Hold. JKHY presents a high-quality business trapped in a negative momentum cycle; the current price reflects known risks, but a catalyst for a sustained reversal is not yet evident. The mixed analyst sentiment, with recent upgrades countering the stock's severe underperformance, supports a neutral stance as the market searches for a new equilibrium.
Supporting Evidence: The hold rating is supported by four key data points: 1) The forward P/E of 21.95x, derived from an estimated EPS of $7.77, offers a more reasonable entry point than the trailing multiple. 2) Revenue, while decelerating, remains positive at ~8% YoY. 3) Profitability metrics are robust, with net and operating margins of 19.19% and 23.94%, respectively. 4) The exceptional financial strength, with zero debt and strong FCF, provides a substantial margin of safety against operational mishaps.
Risks & Conditions: The two biggest risks are prolonged revenue growth deceleration below 5% and a break below the $144 technical support level triggering further technical selling. This Hold would upgrade to a Buy if the stock stabilizes above $160 with a confirmation of revenue re-acceleration above 9% YoY and expanding margins. It would downgrade to a Sell if quarterly revenue growth falls below 5% or if the forward P/E expands back above 25x without corresponding earnings growth. Relative to its own history and the growth it offers, the stock is currently fairly valued to slightly overvalued, demanding proof of re-accelerating growth to justify a higher multiple.
Sign up to view all
JKHY 12-Month Price Forecast
JKHY is a fundamentally sound company caught in a valuation reset. The AI assessment is neutral based on the offsetting forces of excellent financial health against clear growth and momentum headwinds. The forward P/E offers a more reasonable entry, but the stock needs to demonstrate it can stabilize its growth rate to attract new buyers. Confidence is medium due to the high short interest and lack of a clear near-term catalyst. The stance would turn bullish on evidence of sequential revenue re-acceleration for two consecutive quarters. It would turn bearish on a breakdown below the $144 support level on high volume.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Jack Henry & Associates's 12-month outlook, with a consensus price target around $174.24 and implied upside of +30.0% versus the current price.
Average Target
$174.24
10 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
10
covering this stock
Price Range
$107 - $174
Analyst target range
The stock is covered by 8 analysts, and recent institutional ratings show a mixed but generally constructive sentiment, with recent actions including an upgrade to Overweight by Wells Fargo and an upgrade to Outperform by Wolfe Research. A consensus recommendation is not explicitly provided, but the pattern of recent ratings suggests a leaning towards Neutral to Positive views. The average target price is not provided in the data, so the implied upside or downside cannot be calculated; however, the presence of several 'Buy' and 'Outperform' ratings from firms like DA Davidson and RBC Capital indicates a segment of the analyst community sees value at current levels. The target price range is also not available in the dataset, preventing analysis of the high and low target assumptions; the recent rating changes, including the upgrade from Wells Fargo, signal that some analysts believe the sell-off may be overdone and that the company's fundamentals remain intact, though the lack of a tight price target spread from the data suggests some degree of uncertainty remains regarding the near-term outlook.
Bulls vs Bears: JKHY Investment Factors
The investment debate for JKHY is a classic clash between strong fundamentals and weak technicals. The bull case, supported by a pristine balance sheet, consistent profitability, and analyst upgrades, appears to have stronger long-term evidence. However, the bear case currently dominates price action, evidenced by severe underperformance, decelerating growth, and high short interest. The single most important tension is whether the company's high-quality, defensive business model can reassert itself to justify its still-premium valuation, or if the technical breakdown and growth deceleration will lead to further multiple compression. The resolution hinges on the next few quarters of revenue growth and margin stability.
Bullish
- Exceptional Balance Sheet Strength: The company operates with zero debt (debt-to-equity of 0) and a current ratio of 1.27, providing immense financial flexibility. This fortress balance sheet, coupled with trailing twelve-month free cash flow of $654.23 million, allows for continued dividend payments (36.13% payout ratio) and share repurchases without external financing risk.
- Consistent Profitability & High Margins: JKHY maintains robust profitability with a net margin of 19.19% and an operating margin of 23.94% in its latest quarter. This demonstrates the resilience and pricing power of its core processing and payment services, generating a healthy return on equity of 21.39%.
- Analyst Upgrades Signal Value: Recent analyst actions, including upgrades to Overweight by Wells Fargo and Outperform by Wolfe Research, suggest professional sentiment is turning positive after the stock's significant decline. This indicates a belief that the sell-off, which saw a 23.57% drawdown, may be overdone relative to the company's stable fundamentals.
- Attractive Forward Valuation: The stock's forward P/E of 21.95x is a significant discount to its trailing P/E of 28.88x, implying the market expects earnings growth. Based on the forward EPS estimate of $7.77, the current price reflects a reasonable multiple for a company with its profitability and cash flow profile.
Bearish
- Severe Technical Downtrend & Underperformance: The stock is down 11.42% over the past year and 14.05% over three months, drastically underperforming the S&P 500 by over 40 percentage points on a 1-year basis. Trading near its 52-week low of $144.12, the persistent selling pressure and negative relative strength of -11.01 over the past month indicate a clear lack of buyer conviction.
- Revenue Growth Deceleration: Year-over-year revenue growth decelerated to 7.93% in Q2 FY2026, down from 10.2% in the prior quarter. This sequential slowdown, from $644.74M to $619.33M in quarterly revenue, raises questions about the near-term growth trajectory in a potentially challenging macro environment for financial technology.
- Premium Valuation Despite Weak Price Action: Even after the steep decline, the trailing P/E of 28.88x sits above the midpoint of its recent historical range (18.85x to 39x). This suggests the market is still pricing in optimistic expectations, creating valuation compression risk if growth continues to moderate.
- High Short Interest: A short ratio of 5.54 indicates significant bearish sentiment from short sellers. This high level of short interest can act as a persistent overhang on the stock price and amplify volatility, especially if the company fails to deliver positive earnings surprises.
JKHY Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -11.42% and a 3-month decline of -14.05%, significantly underperforming the S&P 500, which gained 29.04% and 4.14% over the same periods, respectively. Currently trading at $154.03, the price sits at approximately 54% of its 52-week range ($144.12 to $193.39), indicating it is much closer to its annual low than its high, which may suggest a value opportunity but also reflects persistent selling pressure and negative sentiment. Recent momentum shows further weakness, with the stock down -1.03% over the past month, diverging sharply from the S&P 500's 9.98% gain, resulting in a severe relative strength reading of -11.01 over that period; this continued underperformance suggests the downtrend is intact and the stock has failed to participate in the broader market rally. Key technical support is clearly defined at the 52-week low of $144.12, while resistance lies at the recent highs near $193.39; a decisive break below support could signal a new leg down, whereas a recovery above resistance would be needed to reverse the bearish trend. The stock's beta of 0.718 indicates it is about 28% less volatile than the market, which is notable given its significant drawdown of -23.57%, suggesting the decline has been driven by company-specific or sector-specific factors rather than broad market volatility.
Beta
0.63
0.63x market volatility
Max Drawdown
-30.4%
Largest decline past year
52-Week Range
$132-$193
Price range past year
Annual Return
-24.7%
Cumulative gain past year
| Period | JKHY Return | S&P 500 |
|---|---|---|
| 1m | -11.5% | +7.7% |
| 3m | -14.5% | +9.7% |
| 6m | -18.3% | +11.3% |
| 1y | -24.7% | +27.3% |
| ytd | -24.9% | +9.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JKHY Fundamental Analysis
Revenue growth remains positive but has shown some sequential deceleration; the most recent quarterly revenue (Q2 FY2026) was $619.33 million, representing a 7.93% year-over-year increase, though this is down from the 10.2% growth seen in the prior quarter (Q1 FY2026: $644.74 million). Segment data indicates a balanced contribution, with Payments ($231.98M), Core ($186.10M), and Complementary ($181.71M) segments all driving the top line, suggesting diversified sources of growth. The company is consistently profitable with a net income of $124.67 million in the last quarter and a robust net margin of 19.19%; gross margin for the quarter was 43.33%, and the operating margin was 23.94%, reflecting healthy profitability levels typical for a software and services business. Profitability metrics have shown some fluctuation quarter-to-quarter, with net income down from $143.99 million in Q1, but the trailing twelve-month free cash flow of $654.23 million underscores strong cash generation. The balance sheet is exceptionally strong with zero debt (debt-to-equity ratio of 0) and a solid current ratio of 1.27, providing significant financial flexibility; the return on equity of 21.39% is healthy, and the substantial free cash flow yield supports the company's ability to fund operations, dividends (payout ratio of 36.13%), and share repurchases without relying on external financing.
Quarterly Revenue
$619334000.0B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.43%
Latest Quarter
Free Cash Flow
$654231000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JKHY Overvalued?
Given the company's consistent profitability (Net Income > 0), the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is 28.88x, while the forward P/E is notably lower at 21.95x; this gap implies the market expects earnings growth, with forward estimates pricing in an earnings per share of approximately $7.77 for the coming period. Compared to sector averages (data not available in the provided set), a precise peer comparison cannot be quantified, but a trailing P/E near 29x for a mid-cap tech services company suggests a premium valuation that would need to be justified by above-average growth or stability. Historically, the stock's own P/E ratio has fluctuated significantly, with recent quarterly historical data showing a range from approximately 18.85x to over 39x over the past several years; the current trailing P/E of 28.88x sits above the midpoint of this recent historical range, indicating the market is still pricing in relatively optimistic expectations despite the recent price decline, likely banking on the company's stable business model and cash flows.
PE
28.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~42x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: JKHY's primary financial risk is not solvency—given its zero-debt balance sheet—but rather growth sustainability and margin preservation. Revenue growth decelerated to 7.93% YoY in the latest quarter, and net income showed a 13% sequential decline, indicating potential earnings volatility. While free cash flow generation is strong at $654M TTM, the company's valuation (P/E of 28.88x) is predicated on steady, profitable growth; any further deceleration could significantly pressure the stock. There is also concentration risk in serving the U.S. regional bank and credit union sector, which is sensitive to interest rates and economic cycles.
Market & Competitive Risks: The stock faces significant valuation compression risk. Despite a 23.57% drawdown, its trailing P/E of 28.88x remains elevated historically, leaving it vulnerable if growth stock multiples contract further. Its low beta of 0.718 suggests the recent underperformance is company or sector-specific, not market-driven, pointing to concerns over its niche market's prospects or competitive threats from larger fintech players. The high short ratio of 5.54 reflects a skeptical market narrative that could perpetuate selling pressure on any negative news.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current trends: revenue growth decelerates further below 5%, margins compress due to competitive or inflationary pressures, and the company misses quarterly earnings estimates. This could trigger analyst downgrades, validate short-seller theses, and lead to a full derating towards its historical P/E low. A realistic downside target would be a retest and break below the 52-week low of $144.12, representing a loss of approximately -6.5% from the current price of $154.03. In a severe sector-wide sell-off, a drop to the $130-$140 range (a -15% to -9% decline) is plausible as investors flee what is perceived as an expensive, slowing growth story.
FAQ
The key risks are: 1) Growth Sustainability: Revenue growth decelerated to 7.93% YoY; further slowing could crush its premium valuation. 2) Technical & Sentiment Risk: The stock is down 11.42% over the past year, underperforming the market by over 40 percentage points, and has a high short ratio of 5.54, indicating persistent negative sentiment. 3) Valuation Compression: A trailing P/E of 28.88x leaves the stock vulnerable to derating if growth disappoints. 4) Sector Concentration: Its fortunes are tied to the health and IT spending of U.S. small and midsize banks, a sector sensitive to economic cycles.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $160 and $175, as steady execution leads to modest earnings growth. The Bull Case (25% probability) targets $185 to $195, requiring a re-acceleration of revenue growth and multiple expansion. The Bear Case (15% probability) warns of a drop to $140-$150 if growth decelerates further and margins compress. The most likely outcome is the Base Case, assuming the company maintains its current trajectory of high-single-digit growth and stable profitability.
JKHY sits in a gray area between fair value and slight overvaluation. Its trailing P/E of 28.88x is high relative to its recent historical range and its current mid-single-digit revenue growth rate, suggesting a premium. However, the forward P/E of 21.95x, based on an estimated EPS of $7.77, is more reasonable and implies the market expects earnings to grow. Compared to its own stellar fundamentals (21.39% ROE, 19.19% net margin), the valuation is understandable but not cheap. The market is paying for quality and stability, not deep value.
JKHY is a good buy for patient, value-oriented investors who prioritize financial strength and profitability over explosive growth. The stock offers a reasonable forward P/E of 21.95x, a strong balance sheet with no debt, and a dividend. However, with revenue growth decelerating to 7.93% and the stock in a clear downtrend, it is not a good buy for momentum traders or those seeking near-term catalysts. The significant 23.57% drawdown has priced in many risks, but a definitive turnaround requires evidence of re-accelerating growth.
JKHY is unequivocally suited for long-term investment, with a suggested minimum holding period of 3-5 years. Its low beta of 0.718 indicates lower volatility relative to the market, aligning with a buy-and-hold strategy. The company's business model—providing essential, sticky technology services—compounds value over time through recurring revenue and high cash flow conversion. Short-term trading is ill-advised due to the stock's current negative momentum, high short interest, and lack of near-term catalysts. Long-term investors can benefit from its dividend, share repurchases, and eventual mean reversion if fundamentals remain intact.